RAD52 is a potential therapeutic target in PARP inhibitor-resistant, BRCA-deficient ovarian cancer von Ota, Yukihide, Gupta, Viju, Fashemi, Bisiayo, Mitra, Sumegha, Zhang, Wendy, Akande, Moreniola, Wallerstein, Seth, Kuroki, Lindsay, McCourt, Carolyn, Hagemann, Andrea, Thaker, Premal H., Mutch, David, Hagemann, Ian, Powell, Matthew, Bitler, Benjamin, Fuh, Katherine, Mullen, Mary, Khabele, Dineo

Volltext

Twenty-Two Health Promotion Pioneers von Goetzel, Ron Z, Parker, Edith, Terry, Paul E, Pasick, Rena J, Burton, Wayne N, Green, Larry, Hunnicutt, David, Palma-Davis, LaVaughn, Eng, Eugenia, Schulz, Amy J, Minkler, Meredith, Anderson, David R, Strecher, Victor J, Katz, David, Serxner, Seth, Whitsel, Laurie, Pronk, Nicolaas P, Wallerstein, Nina, Loeppke, Ron, Resnicow, Ken, Linnan, Laura, Israel, Barbara

Volltext